Kent and Medway Medicines Optimisation Newsletter February 24
• Mounjaro®▼ (tirzepatide) KwikPen® solution for injection
• Wegovy® (semaglutide) solution for injection for Weight Management
• Trurapi® (insulin aspart) 100units/ml solution for injection
• Fezolinetant (Veoza®) – not for NHS prescribing
• Prescribing of Armour Thyroid and other unlicensed desiccated thyroid extract (DTE) products
• Gluten Free Prescribing in Kent and Medway
• Reducing OTC Prescriptions in Primary Care
• East Kent HCP – KCHFT pilot: mucolytic drug holiday initiative
• MHRA Press Release – Pioneering genetic biobank to start recruiting patients on stroke prevention
medicines
• MHRA Drug Safety Update – January 2024
• Shortage of Tegretol 200mg and 400mg prolonged release tablets
• ADHD medication availability and supply disruption update
• Riluzole availability
Kent and Medway Medicines Optimisation Newsletter March 24
• Kent and Medway Dry Eye Guidance - updated
• Reducing ONS Starter Pack Prescriptions in Primary Care
• Prescribing of DPP-4 inhibitors (gliptins) – reminder that sitagliptin is 1st line choice
• Daridorexant for treating long-term insomnia
• Impact of C. Difficile Infections and Management Update – 2nd May 2024
• LMWH Prescribing Pathways in East Kent
• Sharps Bin Provision - Swale Borough Council
• MHRA Drug Safety Update February 2024
• Shortages Summary
• Shortage of Rasagiline 1mg tablets (March 2024)
Kent and Medway Medicines Optimisation Newsletter April 24
• Glaucoma – Generic prescribing
• Eye supplements - Lutein and Antioxidants
• Reminder: Eye Lid Hygiene
• Continence and stoma appliances - Ordering process reminder
• ScriptSwitch® Quantity Limit Switches
• PITstop diabetes on-demand videos
• New SPS Resource – Managing Interactions with Direct Oral Anticoagulants (DOACs)
• BNF Interaction Update: Tramadol – Warfarin Interaction
• MHRA Drug Safety Update March 2024
• NICE News – April 2024
• NHS England: Puberty Suppressing Hormones for Children and Adolescents with Gender Incongruence
• Shortages Summary
• ADHD medication availability and supply disruption update
• Discontinuations of Insulatard® InnoLet® and Levemir InnoLet® 3ml pre-filled disposable devices
Kent and Medway Medicines Optimisation Newsletter May 24
• Adding “Hospital/specialist” medications to a patient’s medication screen on EMIS
• Reminder – MHRA Drug Safety Update 19 April 2022. Pregabalin (Lyrica): findings of safety study on risks
during pregnancy
• Kent and Medway List of New Approved Guidelines from Integrated Medicines Optimisation Committee
(IMOC) April 2024
• Obtaining Anticoagulant alert cards and DOAC booklets
• Methadone Prescribing
• Cost-effective Prescribing of Macrogol Oral Powder Sachets
• PrescQIPP Clinical Masterclass webinars
• UTI diagnostic quick reference tool review consultation - closes 2 June
• MHRA Drug Safety Update
• Shortages Update
Kent and Medway Medicines Optimisation Newsletter June 24
• Eprex to Retacrit switch - Message from East Kent Hospitals UFT for GP Practices
• Reminder – Ongoing GLP-1 RA Supply Issues
• GLP-1 RAs for Weight Management / The risks of inadvertent prescribing and dispensing of injectable
semaglutide (Wegovy®& Ozempic®)
• EasyChamber® spacer devices
• MORPh webinar: SMRs & Medicines Optimisation and Sustainability in Respiratory Care
• Pharmacy First
• Reminder for East Kent Practices – Hospital Only Formulary status for Trimetazidine and Sucralfate
• National Patient Safety alert: Shortage of Pancreatic enzyme replacement therapy (PERT)
• MHRA Drug Safety Update – May 2024
• NICE News – June 2024
• Shortages Summary
Kent and Medway Medicines Optimisation Newsletter July 24
• Clozapine prescribing
• Assessment of a pharmacist’s ability to interpret, review, and action CYP2C19 pharmacogenetic reports and obtain pharmacist’s views on the reporting structure – Deadline 26th July 2024.
• Best Practice Guidance (BPG) for Care Homes
• National Patient Safety – Improvement Programmes
• TARGET Antibiotics – Prescribing in Primary Care
• Webinar: Paediatric antimicrobial prescribing in primary care
• Kent and Medway List of New Approved Guidelines
• MHRA Drug Safety Update
• Shortages summary
Kent and Medway Medicines Optimisation Newsletter August 24
• Ongoing GLP-1 RA Supply Issues – Quantities and Incidents
• FreeStyle Libre 3
• Clozapine Fact Sheet for Primary Care Clinicians
• An Update on Metolazone (Xaqua®) Prescribing in Kent and Medway ICB
• OpenPrescribing Webinar for Primary Care Teams
• Polypharmacy: Medicines and the Risk of Falls in Older People Lunchtime Masterclass
• MHRA Drug Safety Update – July 2024
• NICE News – August 2024
• Specialist Pharmacy Service (SPS) support for medicines shortages - PERT
Kent and Medway Medicines Optimisation Newsletter September 24
• 2024-2045 Medicines Optimisation Quality, Innovation, Productivity and Prevention (Previous MOS Scheme)
• Learning from Near Misses during Anticoagulant switching
• GP Practice Support For Patients Under Early Release Scheme
• Valproate Use in Men: Contraception Use
• PrescQipp Prescribing Mastery Webinars
• MHRA Drug safety Update
• Shortages Summary
Kent and Medway Medicines Optimisation Newsletter October 24
- Topiramate- Implementing MHRA Safety Measures in Kent & Medway
- Antimicrobial Prescribing Guidance
- Reporting a Controlled Drug Issue
- Home Use of Nebulised asthma rescue therapy in children
- Salbutamol SPC update
- The adult attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) service
- REMINDER: Prescribe Apixaban generically
- ScriptSwitch® Prescribing - GP Prescriber Knowledge Centre
- Chlordiazepoxide possible genotoxicity risk and KMPT Alcohol Detox policy update
- Update on the Supply of Semaglutide Injections (Ozempic®) & Prescribing of Tirzepatide Injections (Mounjaro®)
- Ardens Resources for SGLT2i
- Hydroxycarbamide with Continuous Glucose Monitoring Systems
- New RPS and RCGP Repeat Prescribing Toolkit will improve safety and efficiency
- MHRA Drug Safety Update
- Shortages Summary
- NICE News Bimonthly – Oct 2024
Kent and Medway Medicines Optimisation Newsletter November 24
- Kent and Medway ICB Pain Services Community of Practice Webinar
- Rivaroxaban – generic available – All DOACs MUST be prescribed generically
- Independence Wound Protection and Collection Pouches (VAP range) – Non formulary items
- Reminder – Kent and Medway ICB Forceval® capsules Position Statement
- Opioids- Safer Prescribing and Preferred Cost-effective Brands. Information for General Practice
- MHRA Drug Safety Update – October 2024
- Shortages Summary
- Discontinuation NovoRapid® (insulin aspart) FlexTouch® 100units/ml solution for injection 3ml pre-filled pens
- Reminder for East Kent Practices – Oral Morphine Prescribing Resources
Kent and Medway Medicines Optimisation Newsletter December 24/ January25
- Reminder - Registering for MHRA Safety Alerts
- ADHD Medication Supply Disruption Update – November 2024
- TARGET webinars
- Varenicline (Champix)
- National Changes to Community Pharmacy Dispensing Regulations: Original Pack Dispensing
- MHRA Drug Safety Update – November 2024
- Nice news
- Shortages Summary
- Shortage of Quetiapine modified release tablets, (Biquelle XL and Brancico XL)
- Shortage of Fiasp (insulin aspart) FlexTouch 100units/ml solution for injection 3ml pre-filled pens
- Shortage of Tresiba (insulin degludec) FlexTouch 100units/ml solution for injection 3ml pre-filled pens
- Discontinuation of Insulatard® (isophane insulin, human) Penfill® 100units/ml suspension for injection 3ml cartridges
- Discontinuation of saxagliptin/metformin (Komboglyze) 2.5mg/1000mg tablets
Kent and Medway Medicines Optimisation Newsletter January25
- Promethazine Prescribing in NHS Kent and Medway
- Promethazine and Promazine – look alike/sound alike prescribing error
- Vitamin D – Medicines or Food Supplement products
- Discontinuation of Ralvo® Plasters
- My mHealth
- MHRA Drug Safety Update – December 2024
- Shortages Summary
- Preferred
- On Formulary
- Specialist Initiation
- Hospital Use Only
- Unlicensed Medicines